Gene · 58191
Papers4,127
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 4,127
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-Omics Integration Analysis of TK1 in Glioma: A Potential Biomarker for Predictive, Preventive, and Personalized Medical Approaches. | Brain Sci | 2023 | 36831773 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination. | Cancers (Basel) | 2023 | 36831508 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Colorectal Cancer: From Tumor Growth and Metastasis to Biomarkers and Nanomedications. | Cancers (Basel) | 2023 | 36831450 | PubTator, text mining | PubMed |
| Radiotherapy, PARP Inhibition, and Immune-Checkpoint Blockade: A Triad to Overcome the Double-Edged Effects of Each Single Player. | Cancers (Basel) | 2023 | 36831435 | PubTator, text mining | PubMed |
| Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape. | Cancers (Basel) | 2023 | 36831367 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of Macrophage Polarization Protocols: Vitamin D3 or IL-4 and IL-13 Do Not Polarize THP-1 Monocytes into Reliable M2 Macrophages. | Biomedicines | 2023 | 36831144 | PubTator, text mining | PubMed |
| Escin's Multifaceted Therapeutic Profile in Treatment and Post-Treatment of Various Cancers: A Comprehensive Review. | Biomolecules | 2023 | 36830684 | PubTator, text mining | PubMed |
| Potential links between the microbiota and T cell immunity determine the tumor cell fate. | Cell Death Dis | 2023 | 36828830 | PubTator, text mining | PubMed |
| Small extracellular vesicles have distinct CD81 and CD9 tetraspanin expression profiles in plasma from rheumatoid arthritis patients. | Clin Exp Med | 2023 | 36826611 | PubTator, text mining | PubMed |
| Biomarkers (mRNAs and non-coding RNAs) for the diagnosis and prognosis of rheumatoid arthritis. | Front Immunol | 2023 | 36817438 | PubTator, text mining | PubMed |
| Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancer. | Front Oncol | 2023 | 36816977 | PubTator, text mining | PubMed |
| Deciphering the underlying mechanism of liver diseases through utilization of multicellular hepatic spheroid models. | BMB Rep | 2023 | 36814078 | PubTator, text mining | PubMed |
| Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling. | Br J Cancer | 2023 | 36810912 | PubTator, text mining | PubMed |
| Mature dendritic cells enriched in immunoregulatory molecules (mregDCs): A novel population in the tumour microenvironment and immunotherapy target. | Clin Transl Med | 2023 | 36808888 | PubTator, text mining | PubMed |
| Can biomarkers identified from the uterine fluid transcriptome be used to establish a noninvasive endometrial receptivity prediction tool? A proof-of-concept study. | Reprod Biol Endocrinol | 2023 | 36805767 | PubTator, text mining | PubMed |
| Type I IFN stimulates lymph node stromal cells from adult and old mice during a West Nile virus infection. | Aging Cell | 2023 | 36802099 | PubTator, text mining | PubMed |
| Prognostic Significance of the CXCLs and Its Impact on the Immune Microenvironment in Ovarian Cancer. | Dis Markers | 2023 | 36798787 | PubTator, text mining | PubMed |
| Protease allergens as initiators-regulators of allergic inflammation. | Allergy | 2023 | 36794967 | PubTator, text mining | PubMed |
| Interferon alpha inducible protein 6 is a negative regulator of innate immune responses by modulating RIG-I activation. | Front Immunol | 2023 | 36793726 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts: The chief architect in the tumor microenvironment. | Front Cell Dev Biol | 2023 | 36793444 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58191/papers?page=37